Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Virtual

08 may 2025 12:00 p.m. - 08 may 2025 1:00 p.m.

(US Eastern Standard Time)

Rethinking Evidence: Leveraging Real-World Data to Accelerate Drug Development hosted by OM1

Join us to see how RWD, AI, and automation are reshaping observational studies—delivering faster insights, less burden, and regulatory-ready evidence.

Presenters

Nancy  Dreyer, PhD, MPH, FISPE

Nancy Dreyer, PhD, MPH, FISPE

Founder, Dreyer Strategies LLC, United States

Nancy Dreyer is Chief of the Scientific Advisory Board at OM1, and brings her experience having served as Chief Scientific Officer at IQVIA Real World Solutions, Global Chief of Scientific Affairs at Outcome Sciences and Quintiles, and CEO of Epidemiology Resources Inc. Her expertise includes patient-generated information, electronic health records, health insurance claims, and data linkage, including collaboration with regulators and HTA. Widely published, she is a Science and Policy Advisor to DIA and a member of the Real-World Evidence Leadership Team for ISPOR. She is a Fellow of ISPE and DIA, an Adjunct Professor of Epidemiology at University of North Carolina at Chapel Hill and a Trustee of Brandeis University.

Eric  Schrock

Eric Schrock

Chief Technology Officer, OM1, United States

Eric Schrock is Chief Technology Officer and Head of Evidence Generation Solutions at OM1, where he leads a diverse technology team spanning product engineering, data engineering, product management, information security, and IT. He is responsible for shaping and driving OM1's digital strategy and overseeing product development in areas such as data analytics, patient and site experience, and AI-powered personalized medicine. Before joining OM1, Eric was the CTO at Jvion, where he managed teams across product delivery, engineering, professional services, and customer success.

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.